MK1308A , MK4280A, MK6482, MK4830, Pembrolizumab and Lenvatinib
Categoría
Drugs Multinational Subsidiaries
Tipo de registro
Biotech Sanitaria
Nombre socio
Producto / Servicio
MK1308A , MK4280A, MK6482, MK4830, Pembrolizumab and Lenvatinib
Tipo
Biodrugs/ Drugs
Area terapéutica
Oncología
Propiedades/Indicación
Umbrella trial Immune & Targeted Combin Therapies as 1st line treatm in RCC subj w/MK1308A+Lenva or MK4280A+Lenva or MK 6482+Pembro+Lenva vs Pembro+Lenva or as 2nd line & beyond treatm in RCC subj w/MK1308A or MK4280A or MK4830+Pembro or MK6482+Pembro+Len
Fase de desarrollo
P II